Abstract
Tamoxifen (and 4-hydroxytamoxifen), a nonsteroidal triphenylethylene antiestrogenic drug widely used in the treatment of breast cancer, interacts strongly with the respiratory chain of isolated rat liver mitochondria. The drug acts as both an uncoupling agent and a powerful inhibitor of electron transport. Tamoxifen brings about a collapse of the membrane potential. Enzymatic assays and spectroscopic studies indicate that tamoxifen inhibits electron transfer in the respiratory chain at the levels of complex III (ubiquinol–cytochrome-c reductase) and, to a lesser extent, of complex IV (cytochrome-c oxidase). The activities can be restored by the addition of diphosphatidylglycerol, a phospholipid implicated in the functioning of the respiratory chain complexes.
Similar content being viewed by others
References
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
Cabot MC, Giuliano AE, Volnera A, Han TY. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett. 1996;394:129-31.
Chance B, Williams GR. Respiratory enzymes in oxidative phosphorylation. II. Difference spectra. J Biol Chem. 1955;217:395-407.
Custödio JBA, Almeida, LM, Madeira VMC, Madeira MC. The anticancer drug tamoxifen induces changes in the physical properties of model and native membranes. Biochim Biophys Acta. 1993a;1150:123-9.
Custödio JBA, Almeida LM, Madeira VMC. The active metabolite hydroxytamoxifen of the anticancer drug tamoxifen induces structural changes in membranes. Biochim Biophys Acta. 1993b;1153:308-14.
Custödio JBA, Dinis TCP, Almeida LM, Madeira VMC. Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation: evidence for peroxyl radical scavenging activity. Biochem Pharmacol. 1994;47:1989-98.
Custödio JBA, Almeida LM, Madeira VMC. The effect of the anticancer drugs tamoxifen and hydrotamoxifen on the calcium pump of isolated sarcoplasmic reticulum vesicles. Toxicol In Vitro. 1996;10:523-31.
Daum G. Lipids of mitochondria. Biochim Biophys Acta. 1985;822:1-42.
Diolez P, Moreau F. Effect of bovine serum albumin on membrane potential in plant mitochondria. Plant Physiol. 1983;59:177-82.
Dupont J, Schwaller MA, Dodin G. Ditercalinium, a nucleic acid binder, inhibits the respiratory chain of isolated mammalian mitochondria. Cancer Res. 1990;50:7966-72.
Dupont J, Davy de Virville J, Dodin G. Effect of ellipticine, a plant alkaloid, on the respiration chain of plant mitochondria. In: Lambers H, van der Plas LHW, eds. Molecular, biochemical and physiological aspects of plant respiration. The Hague: SPB Academic Publishing bv; 1992:77-86.
Estabrook RW. The low temperature spectra of hemoproteins. Apparatus and its application to a study of cytochrome. Can J Biol Chem. 1956;223:781-94.
Estabrook RW. Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Methods Enzymol. 1967;10:41-7.
Fromson JM, Pearson S, Braman S. The metabolism of tamoxifen (I.C.I. 46,474). Part II: In female patients. Xenobiotica. 1973;3:711-4.
Fry M, Green DE. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. Biochem Biophys Res Commun. 1980;93:1238-46.
Fry M, Green DE. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J Biol Chem. 1981;256:1874-80.
Goormaghtigh E, Brasseur R, Ruysschaert JM. Adriamycin inactivates cytochrome-c oxidase by exclusion of the enzyme from its cardiolipin essential environment. Biochem Biophys Res Commun. 1982;104:314-20.
Goormaghtigh E, Huart P, Brasseur R, Ruysschaert JM. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. Biochim Biophys Acta. 1986;861:83-94.
Harper MJK, Walpole AL. A new derivative of triphenylethylene: effect on implantation and mode of action in rats. J Reprod Fertil. 1967;13:101-19.
Hatefi Y, Stiggall DL. Preparation and properties of succinateubiquinone oxidoreductase (complex II). Methods Enzymol. 1978;53:21-7.
Jordan VC. Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res Treat. 1990;15:125-36.
Jordan VC. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer. Annu Rev Pharmacol. 1995;35:195-211.
Kapuscinki J, Traganos F, Darzynkiewicz Z. Interaction of antitumor drug ditercalinium with nucleic acids in solutions and in situ. Cancer Lett. 1988;42:185-91.
Lien EA, Solheim E, Veland PM. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res. 1991;51:4837-44.
Markovits J, Pommier Y, Mattern MR, et al. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II. Cancer Res. 1986;46:5821-6.
Nayfield SG, Karp JE, Ford LG, Dorr FA, Karmer BS. Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst. 1991;83:1450-9.
Nicolay K, de Kruijff B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim Biophys Acta. 1987;892:320-30.
Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609-18.
Robinson NC. Specificity and binding affinity of phospholipids to the high-affinity cardiolipin sites of beef heart cytochrome-c oxidase. Biochemistry. 1982;21:184-8.
Shimomura Y, Ozawa T. Boundary phospholipids in complex III of mitochondrial electron-transfer chain. Biochem Int. 1981;2:313-8.
Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron transport system associated with the outer membrane of liver mitochondria. J Cell Biol. 1967;32:415-38.
Subba Reddy KV, Hendler RW. Complete analysis of the cytochrome components of beef heart mitochondria in terms of spectra and redox properties. The b-type cytochromes. J Biol Chem. 1983;258:8568-81.
Tolbert NE. Isolation of subcellular organelles of metabolism on isopycnic sucrose gradients. Methods Enzymol. 1974;31:734-46.
Touraine P, Kuttenn F, Mauvais-Jarvis P. Prévention hormonale du cancer du sein: le tamoxifene ne est-il un bon choix? MS-Med Sci 1993;9:1386-91.
Trumpower BL, Gennis RB. Energy transduction by cytochrome complexes in mitochondrial and bacterial respiration: the enzymology of coupling electron transfer reactions to transmembrane proton translocation. Annu Rev Biochem. 1994;63:675-716.
Wikström MKF. The different cytochrome b components in the respiratory chain of animal mitochondria and their role in electron transport and energy conservation. Biochim Biophys Acta. 1973;301:155-93.
Wikström MKF, Casey R. The oxidation of exogenous cytochrome c by mitochondria. Resolution of a long-standing controversy. FEBS Lett. 1985;183:293-8.
Wiseman H. Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol Sci. 1994;15:83-9.
Young RC, Ozols RF, Myers CE. The anthracycline antineoplastic drugs. N Engl J Med. 1981;305:139-53.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tuquet, C., Dupont, J., Mesneau, A. et al. Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol Toxicol 16, 207–219 (2000). https://doi.org/10.1023/A:1007695308257
Issue Date:
DOI: https://doi.org/10.1023/A:1007695308257